Latest Articles
Advanced Endometrial Cancer Pipeline 2025: FDA Updates, - openPR.com
Advanced Endometrial Cancer Pipeline 2025: FDA Updates, openPR.com
Published: Nov. 18, 2025, 6:59 p.m.
An assisted diagnostic and prognostic model for endometrial cancer using 36 serological markers and clinical variables from 562 patients - Nature
An assisted diagnostic and prognostic model for endometrial cancer using 36 serological markers and clinical variables from 562 patients Nature
Published: Nov. 18, 2025, 2:28 p.m.
The association between metabolic syndrome and incidence of endometrial cancer: a meta-analysis - Diabetology & Metabolic Syndrome
The association between metabolic syndrome and incidence of endometrial cancer: a meta-analysis Diabetology & Metabolic Syndrome
Published: Nov. 17, 2025, 6:01 p.m.
Patients with early Endometrial Cancer who don't undergo Hysterectomy have Higher Mortality: Study - Medical Dialogues
Patients with early Endometrial Cancer who don't undergo Hysterectomy have Higher Mortality: Study Medical Dialogues
Published: Nov. 16, 2025, 4:30 p.m.
Ane Gerda Zahl Eriksson: SENSOR-LIIFE - Advancing Exercise Research in Endometrial Cancer Survivor - Oncodaily
Ane Gerda Zahl Eriksson: SENSOR-LIIFE - Advancing Exercise Research in Endometrial Cancer Survivor Oncodaily
Published: Nov. 16, 2025, 9:57 a.m.
Endometrial Cancer Cure Rate: What Patients Need to Know in 2025 - Oncodaily
Endometrial Cancer Cure Rate: What Patients Need to Know in 2025 Oncodaily
Published: Nov. 16, 2025, 8:17 a.m.
Circulating miRNA as diagnostic tools for gynecological diseases and their applications in biosensor development.
MicroRNAs (miRNAs) have emerged as robust biomarkers for diagnosing and prognosing gynecological diseases due to their disease-specific expression and remarkable stability in body fluids. Despite the inherent instability of RNA …
Published: Nov. 15, 2025, midnight
FDA approves Promega’s OncoMate test to guide personalised treatment for endometrial cancer - Indian Pharma Post
FDA approves Promega’s OncoMate test to guide personalised treatment for endometrial cancer Indian Pharma Post
Published: Nov. 14, 2025, 3:26 p.m.
Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression - Cancer Cell International
Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression Cancer Cell International
Published: Nov. 14, 2025, 4:25 a.m.
Acrivon Therapeutics Advances ACR-368 in Phase 2b Trial for Endometrial Cancer and Prepares for Initial Data on ACR-2316 - Quiver Quantitative
Acrivon Therapeutics Advances ACR-368 in Phase 2b Trial for Endometrial Cancer and Prepares for Initial Data on ACR-2316 Quiver Quantitative
Published: Nov. 13, 2025, 9:25 p.m.
Link copied to clipboard!